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After eliminating Leydig cells in the adult rat testis with ethane dimethanesulfonate 
(EDS), a new population of testosterone-producing Leydig cells forms, arising from stem cells. 
Using isolated rat seminiferous tubules, we showed that stem cells associated with the tubule 
surfaces first proliferated and then differentiated in response to culture with LH. Specific tubule-
secreted factors were shown able to enhance proliferation and differentiation.  In particular, the 
Sertoli cell products FGF2 and PDGFBB increased the proliferation of the stem Leydig cell 
population during the first week of culture, and Desert hedgehog (DHH) was found to commit 
the stem cells to a differentiation pathway during weeks 2−3. With regard to the latter, 3βHSD+ 
cells formed on the surfaces of the tubules in response to DHH that produced testosterone (T), 
and continued to do so for many weeks.  
These results suggested that stem cells residing on the surface of the tubules are 
influenced by endogenous factors coming from the tubules.  We realized that if this was the case, 
the use of cultured tubules would not allow the effects of specific, added factors on stem cell 
proliferation and/or differentiation to be determined. We therefore sought to isolate stem cells 
from the tubules as well as the interstitial tissue. A heterogeneous population of cells, including 
stem Leydig cells, that when isolated from the tubules and cultured in vitro, were found to first 
proliferate in response to FGF2 and PDGFBB in the culture medium, as measured by EdU 
labeling, and then to differentiate in response to Desert hedgehog (DHH) to produce testosterone. 
Thus, the temporal separation observed when culturing whole tubules could be maintained when 




We used both cultured tubules and cells isolated from the tubules to assess the effects of 
the metabolite of diexylhexyl phthalate (DEHP), metabolite mono2-ethylhexyl) phthalate 
(MEHP) on the proliferation and on differentiation of the stem Leydig cells.  Tubules were 
cultured with LH alone, LH + 0.2 µg/ml MEHP or LH + 1 µg/ml MEHP for up to 24 days. A 
dose-dependent decrease in testosterone production was seen in response to MEHP. With stem 
cells obtained from seminiferous tubules, in vitro culture with LH for 1 week resulted in cell 
proliferation. When the isolated cells were cultured with LH + 0.1 µM MEHP, greater numbers 
of EdU-labeled cells were apparent after 1 week compared to culture with LH alone. When 2 µM 
DHH was added after week 1, testosterone production was greater by cells that had been cultured 
with MEHP during week 1 than cells cultured with LH alone, perhaps reflecting the greater 
numbers of cells resulting from MEHP exposure. To examine phthalate effects on cell 
differentiation, the cells were incubated in LH (10 ng/ml) for week one, and then during week 2 
with LH alone or LH plus MEHP of increasing dose, and finally with 2µM DHH. Phthalate 
exposure during the second week had inhibitory effects on T production compared to LH−alone 
controls, with the higher doses more inhibitory than lower doses. These studies indicate that: 1) 
the novel system developed for examining stem Leydig cell function should be useful in studying 
the effects of environmental toxicants on Leydig cell development and function; 2) as with 
cultured seminiferous tubules, isolated stem Leydig cells cultured in vitro can be induced to first 
proliferate (week 1) and subsequently differentiate (weeks 2-3); that is, the temporal separation 
observed when culturing whole tubules is maintained when culturing isolated stem Leydig cells; 
3) the cells can be induced to proliferate by culture with PDGFBB and FGF2; 4) cells can be 




testosterone for long periods of time; 6) the isolated cells can be used to examine factors that 
influence their proliferation and differentiation in the absence of influence from the seminiferous 
tubules; and 7) this system provides a way to assess the effects of exposure to environmental 
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Leydig Cell Structure and Function 
Leydig cells are the cells in the interstitial region of the testes responsible for the 
production of testosterone [Chen et al, 2009; Habert et al, 2001]. It has been determined that 
there are two distinct populations of Leydig cells in the testis throughout the life of a male 
[Habert et al, 2001; Kerr and Knell, 1988; Teerds et al, 2007]. First are the fetal Leydig cells. 
These cells are responsible for producing masculinizing doses of testosterone necessary for male 
development [Habert et al, 2001; O’shaughnessy et al, 2006]. For instance, testosterone produced 
by fetal Leydig cells is essential for the differentiation of the male urogenital system and for 
scrotal descent of the testis [Chen et al, 2009; Habert et al, 2001; O’shaughnessy et al, 2006; 
Zhang et al, 2008]. There is a peak in fetal androgen production just prior to birth to ensure 
proper masculinization of the fetus [O’shaughnessy et al, 2006]. The majority of this cell 
population regresses after the initial masculinization is complete, but some fetal Leydig cells are 
believed to persist into adult life [Habert et al, 2001; Kerr and Knell, 1988].  There are three 
main morphological features that distinguish fetal Leydig cells from other cell types of the fetal 
testis and from the adult Leydig cells. They have an irregularly-shaped oval nucleus with a 
nucleolus, there is a visible rim of cytoplasm, and they have an abundance of cytoplasmic lipid 
inclusions for steroid biosynthesis [Kerr and Knell, 1988]. The fetal Leydig cells also form 
clusters and bundles [Kerr and Knell, 1988]. These cells express the luteinizing hormone (LH) 
receptor and respond to LH from the anterior pituitary gland, but they do not require LH 
stimulation to produce testosterone [Zhang et al, 2008]. This is just one of many factors that sets 




In humans, adult Leydig cells form from puberty to adulthood and are the primary source 
of testosterone production in males [Chen et al, 2009; Zhang et al, 2008]. The adult Leydig cells 
are significantly larger than the fetal Leydig cells and are not bundled together [Habert et al, 
2001, Kerr and Knell, 1988]. They contain few cytoplasmic lipid inclusions, but rather have a 
greater abundance of smooth endoplasmic reticulum and mitochondria [Kerr and Knell, 1988]. 
The testosterone produced by the adult Leydig cells provides the androgens necessary for 
spermatogenesis and many other male reproductive functions [Chen et al, 2009; Habert et al, 
2001; Kerr and Knell, 1988; Zhang et al, 2008]. Unlike the fetal Leydig cells, adult Leydig cells 
are absolutely dependent on LH from the anterior pituitary gland to synthesize testosterone 
[Habert et al, 2001; O’shaughnessy et al, 2006; Teerds et al, 2007].  
Testosterone production in the male is regulated by the hypothalamic-pituitary-gonadal 
axis. Gonadotropin-releasing hormone (GnRH) is produced by the hypothalamus, and acts on the 
anterior pituitary to stimulate the release of gonadotropins LH and follicle stimulating hormone 
(FSH) into circulation throughout the body [Ivell et al, 2014]. These peptide hormones bind 
specific cell-surface receptors in the testes to carry out their effects. FSH in males plays a crucial 
role in initiating spermatogenesis. LH is critically involved in testosterone production by ALCs. 
Specifically, LH binds the LH receptor (LHR) on Leydig cells to stimulate testosterone 
synthesis. LH binding the LHR and then coupling to G-protein-coupled receptors (GPCRs) 
stimulates the production of adenylate cyclase, which results in cAMP production. cAMP then 
stimulates steroid hormone biosynthesis through a cholesterol-mediated pathway [Ivell et al, 
2014]. When there is enough testosterone sensed in the body, its presence negatively feeds back 




released, and testosterone is no longer made [Chimento et al, 2014]. When testosterone levels 
begin to get too low, the hypothalamus is no longer inhibited by testosterone, so it releases 
GnRH and the cycle of testosterone production resumes [Chimento et al 2014]. This negative 
feedback cycle of pulses of GnRH stimulating pluses of LH stimulating pulses of testosterone is 
responsible for the maintenance of testosterone levels in the body.  
The building block of all steroid hormones is cholesterol, and its conversion into steroid 
hormones is tightly regulated by various enzymes in the mitochondria and smooth endoplasmic 
reticulum [Habert et al, 2001; Martinez-Arguelles et al, 2013]. The rate-limiting step of 
steroidogenesis is the import of cholesterol (either from the extracellular space or made de novo 
within the cell) into the mitochondria [Jefcoate, 2006; Martinex-Arguelles et al, 2014; Rone et al, 
2009]. This key step is facilitated by steroidogenic acute regulatory protein (StAR) and 
translocator protein (TSPO) after the cell has responded to LH [Habert et al, 2001; Martinez-
Arguelles et al, 2013]. Once in the inner mitochondrial membrane, cholesterol is cleaved into 
pregnenolone by P450scc (CYP11A1). From here, pregnenolone enters the smooth ER where, 
through a series of enzymatic reactions, testosterone is synthesized [Habert et al, 2001; Martinez-
Arguelles et al, 2013] (Fig. 1). 
Stem Cells 
Stem cells are defined by their unique ability to both self-renew and differentiate into 
various cell types in the body [Zhang et al, 2008]. There are different classes of stem cells, based 
on their differentiation capacity. Stem cells are classified as totipotent, pluripotent, multipotent, 




Stem cells first differentiate into progenitor cells, which have the ability to commit to and 
develop into specific cell types [Kumar et al, 2010]. The potency of a stem cell will dictate how 
many cell types that stem cell can differentiate into. Totipotent stem cells have the ability to 
differentiate into all the embryonic and extraembryonic cell types of the body [Kumar et al, 
2010]. Pluripotent stem cells are the next class of stem cells. They have the ability to 
differentiate into any cell derived from the mesoderm, endoderm and ectoderm [Kumar et al, 
2010]. Multipotent stem cells can differentiate into cell types within a specific family of cells 
[Kumar et al, 2010]. Lastly, unipotent stem cells can differentiate into only one specific cell type, 
while continuing to self-renew to maintain the cell population [Kumar et al, 2010].   
Adult stem Leydig cells have been reported to localize to both the peritubular and 
perivascular regions of the interstitial space of the postnatal testis [Zhang et al, 2008]. In rodents, 
there have been two generations of Leydig cells identified, as mentioned above—fetal Leydig 
cells and adult Leydig cells [Zhang et al, 2008]. Fetal Leydig cells are present during gestation, 
and differentiate from a fetal stem Leydig cell population [Zhang et al, 2008]. This cell 
population is essential for masculinization of the fetus. By embryonic day 12 in rats, the fetal 
Leydig cells are committed and have begun differentiating leading to testosterone biosynthesis 
[Zhang et al, 2008]. After birth, however, fetal Leydig cells regress and contribute negligible 
amounts of androgens to the male [Zhang et al, 2008].  
Adult Leydig cells form in three phases from adult Leydig stem cells that are present in 
the testis at birth [Ge et al, 2006; Zhang et al, 2008]. The formation of these cells requires cell 
proliferation, morphological differentiation, and the ability of the cells to produce testosterone 




monitored by the presence (or absence) of stem cell specific markers, and/or Leydig cell-specific 
markers.  For example, the expression of Leydig-cell specific marker, 3βHSD is used to 
demonstrate cells that have committed to the Leydig cell lineage [Zhang et al, 2008]. The stem 
Leydig cells express genes for platelet derived growth factor receptor-α (PDGFR-α), which is 
specific for Leydig precursor cells [Ge et al, 2006; Odeh et al, 2014].  They also are positive for 
stem cell factors such as leukemia-inhibitory factor (LIF), the LIF-receptor and c-kit, and for 
GATA-binding protein 4, which is a Leydig cell lineage marker. They do not express 3βHSD or 
the LHR, demonstrating their lack of differentiation [Ge et al, 2006; Odeh et al, 2014; Zhang et 
al, 2008]. The first phase that these stem cells transition into is the progenitor Leydig cells, 
which divide a rapid but finite number of times [Zhang et al, 2008]. These cells form after 
proliferation of the stem cells. They express 3βHSD and commit to the progenitor phase by the 
second week of postnatal life in rats [Benton et al, 1995; Ge et al, 2006; Zhang et al, 2008]. 
These cells also express mRNA and proteins that are essential for steroidogenic function 
including P450scc, P450c17, and the LHR [Zhang et al, 2008]. These cells must be stimulated 
with LH to produce low levels of testosterone. While they do not produce much testosterone, 
they have high rates of testosterone metabolism [Chen et. al, 2009; Ge et al, 2006].  
Following the progenitor Leydig cell stage is the immature Leydig cell stage (ILC). In rat 
testes, these cells are usually seen between PND28-56 [Zhang et al, 2008] A defining feature of 
cells in this stage is that they contain abundant smooth endoplasmic reticulum and have 
increased amounts of lipid droplets, to allow for the production of steroid hormones [Zhang et al, 




et al, 1995]. The primary androgen produced at this stage is 5α -androstanediol [Benton et al, 
1995; Zhang et al, 2008].  
Finally, by day 56 in rats, adult Leydig cells are seen [Benton et al, 1995; Zhang et al, 
2008]. Morphologically, these are large cells with copious amounts of smooth ER, few lipid 
droplets, a large nucleolus and high levels of steroidogenic enzymes to facilitate the production 
of testosterone [Benton et al, 1995; Zhang et al, 2008]. This cell population appears at puberty 
and the testosterone produced enables spermatogenesis to occur and aids in maintaining male 
reproductive health and function [Zhang et al, 2008]. Adult Leydig cells are the chief cell 
population in a mature testis. In the rat, there are approximately 25 million Leydig cells [Benton 
et al, 1995; Zhang et al, 2008]. The adult Leydig cells have a low rate of turnover. However, if 
they are destroyed they do have regenerative capabilities due to the persistent stem cell 
population present in the adult testis [Benton et al, 1995; Teerds et al, 1999]. Markers specific 
for adult Leydig cells include 3βHSD, insulin-like growth factor 3, and LHR expression, as well 
as other genes necessary for steroid biosynthesis such as P450scc and P450c17 [Stanley et al, 
2011].   
While there are countless populations of stem cells in the body, each population is 
established in a specific niche. The niche is defined by both its anatomic location in the body and 
its function [Scadden, 2006]. Anatomically, the niche provides a habitat or architecture for the 
stem cells to reside, while functionally, its role is to regulate the stem cell population and 
facilitate differentiation and tissue development or regeneration whenever necessary [Scadden, 
2006]. Often, the niche is comprised of a mix of cell types and extracellular-matrix proteins that 




and fate by facilitating the secretion of various paracrine factors [Scadden, 2006]. For Leydig 
cells, the seminiferous tubules have recently been identified as a potential Leydig stem cell niche 
[Li et al, 2016; Stanley et al, 2011]. Adult Leydig cells in the interstitial space communicate 
closely with neighboring seminiferous tubules. They provide the tubules with the testosterone 
necessary to facilitate spermatogenesis while the tubules secrete various factors that influence the 
fate of the stem cells—either facilitating their proliferation or differentiation. In terms of 
regulating stem Leydig cell development, there are certain niche-specific and Sertoli cell 
secreted factors that influence their proliferation and differentiation in a temporally distinct 
fashion [Li et al, 2016].   
Phthalates 
Phthalates—synthetic diesters of phthalic acid—are a family of plasticizing chemicals 
that are used in various medical devices and consumer products [Buckley et al, 2012; Kavlock et 
al, 2006; Schettler, 2006]. Products they are used in include children’s toys, furnishing, clothing, 
detergents, medical devices, food packaging/storage containers, cars, and cleaning materials 
[Buckley et al, 2012; Kavlock et al, 2006; Kilcoyne et al, 2014]. They are used both to provide 
rigidity to polymeric materials, and to act as solvents to provide lubrication/flexibility [Schettler, 
2006]. The two most abundant phthalates used are di-n-butyl phthalate (DBP) and di-2-
ethylhexyl phthalate (DEHP) [Zhang et al, 2008]. For example, DEHP is added to many medical 
devices made from polyvinyl chloride to increase their flexibility [Akingbemi et al, 2001; 
Kavlock et al, 2006; Latini et al, 2004; Schettler, 2006]. Because they are used in so many 




each year—phthalate exposure is extremely widespread in the developed world [Buckley et al, 
2012; Schettler, 2006].  
The concern surrounding phthalate exposure is that phthalates are endocrine disrupting 
compounds with the potential to impair human reproductive and developmental health 
[Akingbemi et al, 2001]. The monoester metabolites of phthalates such as MEHP and MBP, the 
metabolites of DEHP and DBP, respectively, are what cause reproductive toxicity, in part 
through their actions as anti-androgens. [Borch et al, 2006; David, 2006; Huand et al, 2012]. 
However, while phthalates are classified as anti-androgens, they do not act through the androgen 
receptor [Zhang et al, 2008]. Important windows of sensitivity to phthalate exposure occur in 
utero and during lactation [Zhang et al, 2008]. Phthalates have been shown to disrupt Leydig cell 
structure and function in males, thus leading to abnormal testosterone production, and resulting 
developmental abnormalities such as hypospadias, cryptorchidism and impaired spermatogenesis 
which comprise Testicular Dysgenesis Syndrome (TDS), infertility, and possibly even cancer 
[Akingbemi et al, 2001; Borch et al, 2006; David, 2006; Huang et al, 2012; van den Driesche et 
all, 2014].  
Due to their ubiquitous use, there are many routes through which humans can be exposed 
to phthalates. For example, the chemical can be ingested from food stored in containers made 
with phthalates because phthalates are able to leach out of the plastic in which they are used 
[Akingbemi et al, 2001; David, 2006; Fischer et al, 2013; Kavlock et al, 2006; Schettler, 2006]. 
Additionally, phthalates can be inhaled, absorbed through the skin, passed through bodily fluids, 
or encountered through ambient environmental contamination [Schettler, 2006]. For the general 




[Schettler, 2006]. Infants and toddlers, however, may have exposures several fold higher, 
especially those undergoing therapeutic medical interventions [Schettler, 2006].  
Evidence from human and animal studies supports the contention that fetal programming 
can influence adult testosterone production. It has been shown that programing can be affected 
and, with respect to Leydig cells, manifest by causing decreased levels of testosterone production 
and possibly reproductive disorders in the adult male. [Drake et al, 2009; Eisenberg et al, 2012; 
Kilcoyne et al, 2014; Vanbillemont et al, 2010]. We have hypothesized that early exposure to 
phthalates might affect the Leydig stem cells present in the fetus and in infant males, resulting in 
changes in the proliferation and/or differentiation of these cells and thus in altered steroidogenic 
function of the adult Leydig cells.  
Experiments have shown that phthalates, specifically DEHP and DBP, act in a time, dose, 
and age-dependent manner, and the effects of exposure are therefore determined by the stage of 
development of the fetus or adult [Latini et al, 2004]. Fetal and infant exposures are of greatest 
concern because DEHP, DBP, and other phthalates have the potential to have the most harmful 
effects on these populations. The most common sources of infant exposure to phthalates are 
breast milk, infant formula, baby food, and air containing DEHP coming in contact with the skin 
and/or mouth [Latini et l, 2004]. Congenital cryptorchidism is one of the reproductive disorders 
that falls under the umbrella of TDS, and has been shown to be associated with in utero and 
infant phthalate exposures. For example, a Danish study found a correlation between phthalates 
in breast milk and increased incidence of cryptorchidism [Krysiak-Baltyn et al, 2012]. An 
additional study looked at the relationship between phthalates in maternal breast milk and altered 




the monoester metabolites of phthalates affected Leydig cell function [Main et al, 2006]. 
Specifically, there was a dose-dependent, negative correlation between metabolite concentration 
in breast milk and free testosterone production in infant males [Main et al, 2006].  
Exposure is dramatically increased for infants who are in the neonatal intensive care unit 
because DEHP is frequently used to make the medical devices that are used on these babies for 
prolonged periods of time [Fischer et al, 2013; Latini et al, 2004]. Additionally, these infants 
often have immature metabolic systems, specifically reduced cytochrome p450 function, and 
therefore are at risk for extended exposure to phthalates and their metabolites [Fischer et al, 
2013]. Neonatal exposure occurs most often through the use of different medical tubes 
manufactured with phthalates such as nasogastric tubes, enteral feeding tubes, umbilical 
catheters, oxygenation tubing, and endotracheal tubing [Fischer et al, 2014; Weuve et al, 2006]. 
Additionally, due to the leeching nature of phthalates, bags used to distribute blood and other 
fluids and gloves used by physicians can become contaminated with DEHP [Fischer et al, 2014; 
Weuve et al, 2006]. The main concern for exposed neonates is altered male reproductive function 
[David, 2006; Fischer et al, 2014]. Studies performed in rats showed that neonatal exposure 
results in testicular damage, seminal duct atrophy, germ cell degradation and hypo-fertility 
[Fischer et al, 2014]. The mechanisms for these adverse effects, however, are still under 
investigation, and will be addressed later in this review.  
In addition to infant exposures are the issues of prenatal/in utero exposures, and how 
exposure to phthalates during gestation can cause lifelong adverse effects. When a pregnant 
mother is exposed to phthalates, studies show that the chemical penetrates the placenta and thus 




development of the reproductive tract during pregnancy that endocrine disrupting compounds, 
such as phthalates, act to alter normal developmental processes and have a toxic effect. In the 
case of phthalates in utero exposure leads to irregular sexual differentiation and testosterone 
production, and subfertility later in life, implying that these in utero exposures may be affecting a 
cell population that persists throughout the adult male life [Bornehag et al, 2015; Huang et al, 
2012].  
While there is correlational evidence between endocrine disruptor exposure and increased 
incidences of testicular cancer, TDS, and reduced semen quality, laboratory in vitro and in vivo 
studies are necessary to identify the mechanisms through which phthalates act to cause adverse 
reproductive health outcomes in males. Rodents are used as a model organism for these studies 
because phthalates are a known male reproductive toxicant in rats, and a major target of toxicity 
is the developing testis [Mylchreest et al, 1990; Mylchreest et al, 1999; Mylchreest et al, 2000; 
Shultz et al, 2001]. Various studies have been performed to examine the toxicity of phthalates at 
different doses and at different stages of in utero and postnatal development. Major issues are 
identifying the mechanism behind which these in utero exposures impair Leydig cell 
development and function, and how this ultimately leads to the development of TDS, infertility, 
and other reproductive disorders in males at different stages of life.  
Stem Leydig Cell Identification and Classification  
Leydig cells are now known to differentiate from precursor cells, previously referred to 
as the progenitor Leydig cell (PLC) population. The PLCs are 3βHSD+ and LHR+ [Ge et al, 




undifferentiated SLC population that is present in the neonatal testis. SLCs are 3βHSD and LHR-
negative, but PDGFRα-positive [Ge et al, 2006].  
Initial in situ experiments were performed to identify the putative SLC population in the 
neonatal testis. On postnatal day 7 (PND7), testis sections revealed spindle-shaped cells were 
3βHSD-negative but BrdU positive, demonstrating that the cells they identified were actively 
dividing [Ge et al, 2006]. These cells were localized to the peritubular layer of the testis sections 
[Ge et al, 2006]. However, by PND14, the spindle-shaped cells in the peritubular layer were now 
3βHSD-positive, denoting their transition from putative SLCs to PLCs [Ge et al, 2006]. Subsets 
of cells were also BrdU positive, confirming that they were derived from the originally 3βHSD-
negative putative SLC population [Ge et al, 2006].  
The next experiment sought to characterize the putative SLCs from the neonatal testis 
and assessed their ability to both proliferate and differentiate, which would give them the 
necessary characteristics to be considered a stem cell. Putative SLCs were isolated on PND 0, 7, 
14, and 21. Cells isolated at PND 0 and 7 were nearly all 3βHSD-negative, consistent with 
putative SLCs previously characterized as 3βHSD-negative [Ge et al, 2006]. In contrast, 90% of 
the cells isolated at PND 14 and 21 were faintly stained for 3βHSD, and about 5% were intensely 
stained for 3βHSD, perhaps implying that the putative SLCs had begun to differentiate and 
transition into PLCs at this stage [Ge et al, 2006]. Additionally, upon examining the differences 
between the faintly and intensely stained cells, it was found that the intensely stained cells were 
remaining fetal Leydig cells and thus were sorted and removed for all further experiments [Ge et 
al, 2006]. The remaining 3βHSD-negative, PDGFR-α-positive cells were then characterized to 




negative PDGFR-α-positive putative SLCs. These cells were found to express leukemia 
inhibitory factor receptor (LIFR) and c-kit, two known markers of stemness [Ge et al, 2006]. 
Additionally, these cells were Gata4-positive, which is a transcription factor that plays a role in 
Leydig cell development [Ge et al, 2006]. When plated in expansion media containing leukemia 
inhibitory factor (LIF) and PDGF, putative SLCs were shown to continue to expand without 
differentiating for over 6 months [Ge et al, 2006]. The cells remained LHR-negative and 
PDGFR-α-positive [Ge et al, 2006].  
To assess the ability of putative SLCs to differentiate in vitro, the LHR-negative, 
PDGFR-α-positive cells were placed in DIM containing LH, insulin-like growth factor-I, thyroid 
hormone, and PDGF. After 7 days in culture, many cells became LHR-positive and began to 
express enzymes and proteins involved in Leydig cell differentiation and steroidogenesis [Ge et 
al, 2006]. These include steroidogenic acute regulatory protein (StAR), P450scc, 3βHSD, and 
P450c17 [Ge et al, 2006]. Additionally, these cells remained PDGFR-α-positive, and expressed 
Gata4 and stem cell factor-1, both of which are specific for Leydig cell development [Ge et al, 
2006]. Testosterone was measured in culture media and shown to increase as a function of time 
in culture [Ge et al, 2006]. These experiments provided evidence that the putative SLCs were 
able to both proliferate and differentiate.  
Lastly, the ability of the putative SLCs to repopulate EDS-treated testes and differentiate 
into testosterone-producing Leydig cells was assessed. LHR-negative, PDGFR-α-positive cells 
were isolated and fluorescently labeled. They were then injected into the testes of rats devoid of 
Leydig cells by virtue of prior injection of the rats with EDS. Ten days later testes were 




testis and to become positively stained for 3βHSD [Ge et al, 2006]. This series of experiments 
provided evidence for the existence of SLCs in the neonatal testis that are capable of giving rise 
to ALCs.  
Knowing that SLCs exist in the neonatal testis and give rise to ALCs, it was then asked 
whether or not this population of stem cells continues to exist and play a role in the adult testis. 
Experiments to prove the presence and functionality of the Leydig stem cells in the adult testis 
involve depleting the existing population of Leydig cells and observing their regeneration. 
Leydig cells are specifically targeted and depleted by ethane dimethanesulfonate (EDS) 
[Davidoff et al, 2004; Kerr et al, 1985; Stanley et al, 2012; Teerds et al, 1999]. Within three days 
of EDS treatment, the Leydig cell population was depleted and serum testosterone levels were 
decreased [Davidoff et al, 2004; Kerr et al, 1985; Teerds et al, 1999]. Afterward, however, a new 
generation of Leydig cells is able to form, suggesting the possibility that the adult Leydig cells, 
identified by the presence of markers such as 3 HSD, P450scc and the LHR, may arise from 
stem cells [Davidoff et al, 2004; Kerr et al, 1985; Teerds et al, 1999]. To determine whether, in 
fact, the new Leydig cells arose from a stem cell population present in the adult, testicular cells 
that were PDGFR-  positive but P450scc-negaitve were isolated from the testes after Leydig cell 
depletion with EDS [Stanley et al, 2011]. PDGFR-  is a growth factor receptor that is specific to 
and required for the commitment of Leydig cell precursors to proliferate and differentiate 
[Stanley et al, 2011]. The isolated cells showed linear growth patterns when observed for 1.5 
years, and they remained P450scc-negative [Stanley et al, 2011]. However, when the cells were 
cultured in media containing LH, they became P450scc-positive and began to produce 




precursors were indeed stem cells because they possess the ability to both self-renew and 
differentiate.  
Within four weeks post-EDS treatment, the Leydig cell population and steroidogenic 
function are restored [Davidoff et al, 2004; Teerds et al, 1999]. Beginning at about day 15post 
EDS, 3 HSD and LHR positive cells began to appear in increasing numbers, and by day 56, the 
Leydig cell population was almost completely restored to its original size of about 25 million 
cells [Stanley et al, 2011; Teerds et al, 1999]. 
Seminiferous tubules were separated from the interstitium four days after rats were EDS 
treated [Stanley et al, 2011]. There were no 3 HSD -positive cells assocated with the tubules or 
the interstitium, which were cultured separately [Stanley et al, 2011]. When tubules were 
cultured in media containing LH, 3 HSD -positive cells appeared on the surface of the tubules, 
and the cells expressed StAR and P450scc [Stanley et al, 2011]. This cell population was not 
present in the cultured isolated interstitium [Stanley et al, 2011]. It was also found that after two 
weeks of culturing tubules with media containing LH, testosterone was detected in the media, 
indicating the cells had differentiated. Overall this confirmed that Leydig cells formed from 
precursor cells associated with the seminiferous tubules [Stanley et al, 2011].  
To confirm that these precursors were stem cells, the capability of the cells to proliferate 
and differentiate was examined. First, cells on the surface of the isolated seminiferous tubules 
were EdU-labeled during the first 72h of culture [Stanley et al, 2011]. Then, after four weeks, the 
cells were examined. A population of the cells remained EdU-positive only, while some EdU-
positive also became 3 HSD positive, indicating their entry into the Leydig cell lineage [Stanley 




on the tubule surfaces were indeed stem cells, tubules were cultured for 7 weeks in media 
containing LH [Stanley et al, 2011]. Then, the tubules were stripped of their newly formed 
Leydig cells with EDS, and cultured again in media containing LH. It was reasoned that if the 
cells that gave rise to Leydig cells in fact were stem cells, new Leydig cells would again reappear 
on the tubule surfaces [Stanley et al, 2011]. Indeed, cells positive for 3 HSD and P450scc did 
reappear and testosterone production was consistent with the appearance or reappearance of 
these cells [Stanley et al, 2011]. These results confirmed the presence of the stem cell population 
and the ability of these cells to both proliferate and differentiate. The ability of the putative stem 
cells to successfully proliferate and differentiate without the blood vessels and immune cells of 
the testis niche suggests that those components of the testis may not be necessary for the 
successful development of Leydig cells. 
 These studies suggested that the seminiferous tubules might represent the niche for 
SLCs. With this in mind, the ability of growth factors and cytokines deriving from the 
seminiferous tubules that were previously identified via microarray analysis to influence the 
proliferation and/or differentiation of the SLCs was assessed using the tubule culture system [Li 
et al, 2016]. The observed temporal separation observed between proliferation and differentiation 
in this system proved to be advantageous in discerning which factors had an effect on one phase 
or another. To assess effects on proliferation, tubules were incubated with LH plus a given factor 
for the first week, then only LH for weeks 2 and 3. To examine effects on the differentiation of 
the SLCs, the tubules were cultured with LH only for week 1, then LH plus a specific factor for 
weeks 2 and 3 in culture. The factors that positively influenced proliferation include PDGFAA, 




demonstrated by measuring both EdU labeling and testosterone production. One of the most 
important findings of this series of experiments was that DHH was concluded to have the ability 
to commit SLCs on the path to differentiating into ALCs [Li et al, 2016].  
Then, Li et al set out to determine a possible marker for SLCs. CD90 was determined to 
be a possible marker for locating and identifying SLCs on the surface of the tubules [Li et al, 
2016]. CD90 was chosen in part because its message levels were found to be upregulated in 
SLCs, then downregulated/off in the PLC stage in previously analyzed microarray data [Li et al, 
2016; Stanley et al, 2011]. CD90 was shown to localize to cells on the surface of freshly isolated 
tubules, which has been shown to be where the stem cells reside [Li et al, 2016]. Myoid cells, 
which also reside on the tubule surface and stain for desmin, did not stain positively for CD90, 
further confirming that distinct populations exist and that CD90 may be specific for the SLC 
population [Li et al, 2016]. Cells on the surfaces of the tubules were isolated from the tubules via 
collagenase digestion and the heterogeneous cell population was then stained for CD90. The 
stained isolated cells were then sorted and cultured. CD90+ cells were able to produce 
testosterone when cultured with LH+SAG (the DHH agonist) [Li et al, 2016]. CD90- cells in the 
same culture conditions produced no testosterone [Li et al, 2016]. This provided the evidence 
that CD90 could be used as a possible marker for stem Leydig cells. The use of these cells 
enables factors involved in stem cell function and dysfunction to be identified apart from the 
seminiferous tubules themselves. 
 
Fetal onset of adult disease, the role of the Leydig stem cell and the effects on Leydig cell 




 When adverse effects related to Leydig cell function are observed in adulthood following 
an early-life exposure to a chemical or environmental toxicant, it may imply that the stem cell 
population was where the toxicant had its most profound effects. This is because, as previously 
demonstrated, it is this stem Leydig cell population rather than the adult Leydig cell population 
that is present during the time of the exposure. Indeed in utero exposure to phthalates have been 
shown to cause an increase in testosterone production either through causing an increase in 
Leydig cell number or by stimulating testosterone production directly when given 1 and 10 
mg/kg/day of DEHP [Ge et al, 2007; Zhang et al, 2008]. This observed increase in testosterone 
production is sufficient to advance the timing of puberty in rats [Ge et al, 2007]. However, in 
utero exposure to doses of DEHP of 100mg/kg bw/day and higher inhibited testosterone 
production. This inhibition was sustained at 6, 12 and 18 months of age after in utero exposure, 
which may suggest that the stem Leydig cells were affected and influence/disturb the maturation 
and function of the adult Leydig cells [Ge et al, 2007].   
Based on the knowledge that there are SLCs present in the neonatal testis, Kilcoyne et al 
[2014]assessed the possible effects of in utero exposure to DBP on SLCs and the development of 
the Leydig cell lineage. When pregnant rats were given 500mg/kg bw/day DBP, intratesticular 
testosterone (ITT) levels were reduced in the male offspring. Specifically, between gestation day 
17.5-21.5 (GD17.5-21.5) there was a 50-70% reduction in ITT. Additionally, there was a 40% 
reduction in Leydig stem cell number at GD21.5, and this deficit was maintained throughout 
adulthood in the rat. They also observed that, when exposed to DBP, there were changes in the 
expression patterns of genes necessary for steroidogenesis and for commitment to the Leydig cell 




[Kilcoyne et al, 2014]. Furthermore, they observed that the reduction of StAR was caused by 
decreased histone methylation of H3K27me3 (a transcriptional repressor). Decreased 
methylation of H3K27me3, resulted in increased expression of H3K27me3, ultimately causing a 
decrease in expression of StAR, one of its known targets. This resulted in a decrease in 
testosterone production. Overall, it is suggested from these results that fetal testosterone levels 
do impact and affect adult Leydig cell number and function, possibly by affecting the stem 
Leydig cell population. 
 Anti-androgenic effects seen from prenatal and perinatal exposures to phthalates most 
likely result in a reduction in testosterone produced late in gestation [Borch et al, 2006]. 
Normally in rats, testosterone levels peak from GD17-GD20 to ensure proper masculinization 
and reproductive tract development, but phthalates such as DEHP and DBP have been shown to 
alter testosterone produced in this window [Borch et al, 2006]. One possible cause for a decrease 
in testosterone is the downregulation of factors necessary for steroid hormone biosynthesis from 
the cholesterol precursor.  
The expression levels of enzymes critical for steroid hormone biosynthesis were analyzed 
following in utero exposure to varying doses of phthalates—specifically DBP and DEHP. 
mRNA and protein expression levels were assessed for SR-B1 which is responsible for 
cholesterol uptake and transport into Leydig cells, StAR, TSPO, P450scc and P450c17 which are 
required for cholesterol translocation into the mitochondria and its subsequent metabolism, and 
nuclear receptors SF-1, PPAR  and PPAR  [Barlow and Foster, 2003; Borch et al, 2006; Ge et 
al, 2007; Lehmann et al, 2004; Lin et al, 2009; Shultz et al, 2001; Thompson et al, 2004]. 




around GD21 in the experiments, with the most drastic effects seen at concentration of 300mg/kg 
bw/day and greater when observed at GD21 [Borch et al, 2006; Ge et al, 2007; Lin et al, 2009; 
Shultz et al, 2001]. For example, there was a dose-dependent reduction in the gene and protein 
expression levels of SR-B1, StAR, TSPO, and P450scc, which is indicative of a downregulation 
of steroid hormone biosynthesis following in utero DEHP exposure, with the most dramatic 
effects seen at the highest concentrations used [Borch et al, 2006]. Additionally expression of 
SF-1 and PPAR  were reduced following exposure to DEHP [Borch et al, 2006]. When exposed 
to 500mg/kg bw/day of DBP downregulation of StAR, P450scc, P450c17, and SR-B1 was seen 
most dramatically at GD16, GD19, and GD21 fetal testes [Ge et al, 2007; Thompson et al, 2004].  
 In addition to assessing the mRNA and protein expression levels for enzymes involved in 
steroidogenesis, Leydig cell functional markers such as insulin-like factor 3 (Insl-3) which is 
necessary for testicular descent, DHH and Patched-1 (Ptc-1) which are necessary for Leydig cell 
differentiation, and development within the interstitial region of the testes were assessed 
following fetal DEHP and DBP exposures [Borch et al, 2006]. This was done in an effort to see 
how phthalates not only affect the steroidogenic function of the Leydig cells, but also the 
development of the Leydig cells themselves. When exposed to DEHP in utero, there was a 
dramatic decrease in the expression of Insl-3 in the fetal testis [Borch et al; Lin et al, 2009]. 
Additionally, following in utero 500mg/kg bw/day DBP exposure, there were increased 
incidences of cryptorchidism and hypospadias in male offspring, and there was increased 
incidence of subfertility in the male mice [Fisher et al, 2003]. Leydig cell hyperplasia was 
observed in fetal testis tissue at GD19 and GD21, and these areas of hyperplasia persisted 




phthalates on male reproductive health [Fisher et al, 2003; Ge et al, 2007; Mahood et al, 2006; 
Shultz et al, 2001].  
 Serum and intratesticular testosterone levels, and spermatogenesis, also were analyzed 
following in utero DEHP or DBP exposure. At 300mg/kg bw/day of DEHP in utero exposure, 
there was a significant decrease in both serum and intratesticular testosterone production by the 
fetal testes compared to controls when observed at GD21 [Borch et al, 2006]. When exposed to 
500mg/kg bw/day DBP, intratesticular testosterone levels were decreased 90% compared to 
controls at GD19 and GD21, and spermatogenesis was abnormal [Fisher et al, 2003; Shultz et al, 
2001]. Additionally, serum testosterone levels in these rats were reduced at PND25, which shows 
the prolonged effects of in utero exposures [Fisher et al, 2003]. Anogenital distance (AGD) is a 
testosterone-dependent developmental process, and thus was also assessed. In utero phthalate 
exposure was correlated to a decrease in observed anogenital distance. At 500mg/kg bw/day, 
DEHP and DBP each caused a decrease in intratesticular testosterone levels. At this same dose, 
compared to controls, rats exposed to DEHP or DBP had a decreased AGD. [Ge et al, 2007]. 
AGD is most likely to be negatively affected when exposure to DBP occurs during GD15-17 
[Ema et al, 2000]. At 100mg/kg bw/day of in utero DEHP exposure, there was an observed 
decrease in serum testosterone levels at PND21 and PND35 [Ge et al, 2007]. Reproductive tract 
abnormalities and decreased testosterone levels persisted in these rats into adulthood and were 
observed postnatally at 6, 12, and 18 months of age [Ge et al, 2007].  
The above results taken together not only provide evidence for fetal effects of in utero 
exposure, but also suggest that there is a maintenance of impaired function of steroidogenesis in 




The adrenal-testis axis and phthalates  
It is imperative to recognize that while the Leydig cells primarily produce testosterone 
following LH stimulation, there is an additional mechanism through which Leydig cells are 
stimulated to produce testosterone—the adrenal gland. Additionally, while Leydig cells are a 
primary cell type through which phthalates have their adverse effects, they are not the only 
targets or means by which phthalates can cause decreased testosterone production and altered 
reproductive health in males. Again, the adrenal-testis axis is a target and exposure here too 
affects testosterone production. This observation was made when one group observed that the 
decrease in steroidogenic enzymes observed in fetal life from in utero exposure was not 
maintained throughout the adult life, but there were still long-lasting effects of the in utero 
exposure [Culty et al, 2008; Martinez-Arguelles et al, 2009; Martinez-Arguelles et al, 2011]  
The adrenal gland facilitates Leydig cell testosterone production through production of 
aldosterone, which is the ligand that binds the mineralocorticoid receptor (MR) in the nucleus of 
Leydig cells [Ge et al, 2005; Martinez-Arugelles et al, 2009; Martinez-Arguelles et al, 2011]. A 
series of experiments was performed by Ge et al to determine that Leydig cells possess the MR 
and that it functions to produce testosterone when bound by aldosterone through a mechanism 
that is distinct from the canonical LH-mediated pathway of steroidogenesis in Leydig cells. 
mRNA for the MR was detected selectively in Leydig cells in the interstitial tissues of testes, as 
measured by immunohistochemistry [Ge et al, 2005]. Within the Leydig cell, staining was 
apparent in the cytoplasm as well as in the nucleus [Ge et al, 2005]. This data first confirmed that 
Leydig cells may be capable of responding to mineralocorticoids such as aldosterone through the 




To assess whether there were binding sites in Leydig cells for aldosterone, sections of 
Leydig cells were incubated with [
3
H]aldosterone. Binding was analyzed by scintillation 
counting which measures the amount of radioactive material bound—in this case, the amount of 
aldosterone bound to Leydig cells after incubation. This confirmed that the Leydig cells 
possessed [
3
H]aldosterone binding sites, which further confirmed the presence of the MR in 
Leydig cells [Ge et al, 2005]. To then determine the effects of MR stimulation on Leydig cells, 
Leydig cells were incubated with increasing concentrations of aldosterone and testosterone 
production was measured [Ge et al, 2005]. Testosterone production was found to increase as a 
function of incubation with increasing aldosterone concentrations [Ge et al, 2005]. To prove that 
this was a direct result of MR activation, Leydig cells were incubated with both aldosterone and 
an MR antagonist. When this was done testosterone production was greatly hindered [Ge et al, 
2005]. Finally, to demonstrate that the MR stimulation of testosterone production acts 
independently of LH stimulation of testosterone production in Leydig cells, Leydig cells were 
incubated with both aldosterone and LH, and testosterone production was measured. When 
testosterone production was measured and compared to testosterone produced by Leydig cells 
incubated with aldosterone alone, there was an increase in testosterone produced by those cells 
incubated with both ligands, suggesting that the two hormones act in two distinct pathways [Ge 
et al, 2005]. 
 Knowing the mechanisms through which the adrenal gland is able to stimulate 
testosterone production in the Leydig cell, the possibility for phthalate exposure to disrupt this 
process was analyzed. First, the effects of phthalate exposure on the nuclear mineralocorticoid 




determined [Martinez-Arguelles et al, 2009;]. Studies found that in utero DEHP exposure caused 
decreased MR expression in adult rat Leydig cells. These in utero effects were observed at 
PND60 in adult rat Leydig cells [Martinez-Arguelles et al, 2009]. There were both decreases in 
the mRNA and protein expression levels of the MR in the PND60 testis at doses starting at 
100mg/kg/day [Martinez-Arguelles et al, 2009]. Furthermore, downstream genes regulated by 
the MR were affected in the testis by in utero DEHP exposure [Martinez-Arguelles et al, 2009]. 
The deregulation of the MR by DEHP occurred through changes in methylation of the MR-
promoter [Martinez-Arguelles et al, 2009].     
 Additionally, effects of phthalate exposure on the ability of the adrenal gland to produce 
aldosterone were assessed [Ge et al, 2005; Martinez-Arguelles et al, 2011] based on the 
hypothesis that a decrease in aldosterone production by the adrenal gland could lead to a 
decrease in testosterone produced by the Leydig cells because the MR is not properly activated. 
It was observed that not only does DEHP cause decreased expression of the MR in Leydig cells, 
but it also inhibits the synthesis of aldosterone by the adrenal gland [Martinez-Arguelles et al, 
2011]. These two inhibitory actions together cause a reduction of Leydig cell steroidogenesis, 
and may provide insights into the mechanism by which in utero exposures can have sustained 
effects throughout adulthood in males.  
  The above literature review provides evidence for the negative effects of phthalate 
exposure on testosterone production and reproductive health and development in males. 
However, through in vivo experiments, the effect of exposures on the Leydig cell directly is 
extremely difficult to assess. The metabolism of phthalates in the body must be taken into 




importance.  While the experiments by Martinez-Arguelles et al advocate on behalf of alterations 
in testosterone production distinct from changes in steroidogenic enzyme capacity, there is still a 
change in Leydig cell development evidenced by altered MR expression on the Leydig cell as a 
result of exposure to phthalates. Thus, it is critical to be able to examine the effects of phthalates 
on the development and function of the Leydig cell, beginning with the stem Leydig cell 
population. The seminiferous tubule culture system begins to tackle this by removing the testis 
from the whole body system and allows for the progression of the stem Leydig cell in its niche to 
the PLC, ILC and ALC phases to be assessed. While this allows for the development of Leydig 
cells from their stem cell population to be assessed in the context of the niche, this still does not 
allow for direct observation of the effects of phthalate exposure on the Leydig cell alone to be 
determined. In order to determine what the effects of exposing Leydig cells directly to phthalates 
may be, the stem Leydig cells must be digested off of the surface of the tubules and exposed only 
to the niche factors known to be necessary to facilitate their proliferation and differentiation to 
determine how phthalate exposures may alter one or the other in the Leydig cell. Once these 
mechanisms are known then it becomes possible to add back the layers involved when analyzing 
the effects of exposures such as the tubules, the adrenal-testis interactions, and the whole body.  
 
INTRODUCTION 
Leydig cells reside the interstitial compartment of the testis and are the primary source of 
testosterone (T) produced in males [Chen et al, 2009; Habert et al, 2011]. Adult Leydig cells 
(ALC) develop during puberty from a stem Leydig cell (SLC) population that is present in the 




of the postnatal testis [Zhang et. al, 2008]. Once they are established in the testis, the ALCs make 
T and rarely turnover throughout the adult life of the male [Benton et al, 1995; Teerds et al, 
1999]. ALCs form in three phases from the SLCs that are present in the testis—progenitor, 
immature, and then finally adult Leydig cells [Ge et al, 2006; Zhang et al, 2008]. ALCs are 
positive for 3β hydroxysteroid dehydrogenase (3βHSD), an enzyme that is crucial in the 
production of T and is specific for steroidogenic cells [Zhang et al, 2008].   
It has been demonstrated that ALCs can be eliminated from the testis by treatment with 
the alkylating agent ethane dimethanesolfonate (EDS), which selectively targets and kills the 
ALCs [Davidoff et al, 2004; Kerr et al, 1985; Stanley et al, 2012; Teerds et al, 1999]. Following 
their depletion functional, T-producing ALCs are restored to the testes [Davidoff et al, 2004; 
Kerr et al, 1985; Teerds et al, 1999]. It has been demonstrated that the ALCs arise from SLCs 
that remain present in the testis throughout the life of the male [Stanley et al, 2011]. It has further 
been determined that SLCs reside on the surface of the seminiferous tubules [Li et al, 2016; 
Stanley et al, 2011]. There may also be stem cells in the perivascular space within the testis 
[Stanley et al, 2011; Zhang et al, 2008]. Culture of the tubules isolated from EDS-treated rats 
results in temporal separation between the proliferation and differentiation of the SLCs 
associated with the tubules [Li et al, 2016; Odeh et al, 2014]. Proliferation of SLCs is high the 
first week in culture, declines by week 2 and thereafter, and differentiation of the progeny occurs 
beginning week 2 [Li et al, 2016; Odeh et al, 2014]. This is consistent with what is observed in 
vivo [Li et al, 2016; Teerds and de Rooij et al, 1989; Teerds and Rijntjes et al, 1989]. It seems 
likely that both phases, proliferation and then differentiation, are regulated by niche factors 




SLCs can be isolated amongst a heterogeneous cell population from the seminiferous tubule and 
interstitial tissue surfaces and cultured in vitro [Li et al, 2016]. These cells, as is the case of those 
associated with the tubules, are able to proliferate and then differentiate in vitro, when they are 
given the appropriate factors that stimulate them to do so [Li et al, 2016].  
Endocrine disruptors are abundant in the environment and pose a threat to humans on a 
day-to-day basis. These compounds can occur naturally in the environment, or as a consequence 
of man-made chemicals/compounds [Gregoraszczuck and Kovacevic 2013; Kopras et al, 2014]. 
Chemicals and toxicants are classified as endocrine disruptors based on their ability to affect the 
mechanisms through which endogenous hormones regulate cellular functions and thus to affect 
the biosynthesis and/or functioning of steroid hormones [Akingbemi et al, 2001]. There are 
windows of sensitivity during which endocrine disruptors can have dramatic effects on growth 
and development because of the precise developmental regulation the body is under as it matures 
[Zhang et al, 2008].  
There are multiple routes through which humans can be exposed to endocrine disrupting 
compounds. Most common routes of exposure include ingestion, dermal contact and inhalation 
[Martinez-Arguelles et al, 2014]. If a mother is exposed, this exposure can affect the fetus 
through metabolites in umbilical cord blood and amniotic fluid [Martinez-Arguelles et al, 2014; 
Silva et al, 2004]. This exposure can continue postnatally through transmission through breast 
milk [Main et al, 2006; Martinez-Arguelles et al, 2014]. Often, it is the metabolites of the 
chemicals that are toxic and are transmitted from mother to fetus after the mother has been 
exposed [Silva et al, 2004]. These modes of primary and maternal-to-child exposure are shared 




occupational exposure to endocrine disruptors associated with companies manufacturing medical 
devices, plastic toys, and/or plastic containers that contain phthalates or other endocrine 
disruptors [Buckley et al, 2012; Kavlock et al, 2006; Kilcoyne et al, 2014].  
 The objectives in the present studies were: 1) to isolate SLCs from the surface of the 
tubules as well as the interstitial tissues; 2) to determine whether, as with the cells associated 
with the tubules, the isolated cells would proliferate and differentiate and whether the temporal 
separation between the two processes could be maintained; 3) to determine the regulatory 
molecules involved in SLC proliferation and differentiation; and 4) to assess the effects of 
phthalates on the development of functional Leydig cells from stem cells. 
 
MATERIALS AND METHODS 
Chemicals 
 M-199 medium and Click-iT EdU (5-ethynyl-2’-deoxyuridine) kit were from Invitrogen 
(Carlsbad, CA). Collagenase, and Platelet-derived growth factor BB (PDGF-BB) were from 
Sigma Aldrich Company (St. Louis, Missouri). Fibroblast growth factor-2 (FGF2) was from 
Peprote Clinick (Rocky Hill, NJ). Bovine LH (USDA-bLH-B-6) was provided by the U.S. 
Department of Agriculture Animal Hormone Program (Beltsville, MD). 
Insulin/Transferrin/Selenium (ITS) were from Corning (Manassas, VA). DMEN/F12 Medium 
was from Gibco by Life Technologies (Grand Island, NY). Smoothened agonist (SAG), a Desert 
Hedgehog (DHH) agonist, was from Cayman Chemical Company (Ann Arbor, Michigan). 
Mono-(2-ethylhexyl) phthalate (MEHP) (P1073) was purchased from Tokyo Kasei Kogyo Co., 




(Carlsbad, CA). Reverse Transcription Master Mix for cDNA synthesis is from Applied 
Biosystems (Foster City, CA). 2x Taqman qPCR master solution is from Thermoficher 
(Halethorp, MD).  
 
Animal Studies 
 Young adult (~3months of age) male Brown Norway rats were obtained through the 
National Institute on Aging, supplied by Harlan Sprague Dawley Inc. (Indianapolis, IN). 
Animals were housed in Johns Hopkins School of Public Health animal facilities, in controlled 
light (14 hours in light, 10 hours in dark) and temperature (22⁰C) with free access to water and 
rat chow. All procedures were performed in accordance with the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals according to protocols approved by the Johns 
Hopkins Animal Care and Use Committee.  
 
Isolation and culture of seminiferous tubules from adult testis 
 Rats were given a single intraperitoneal injection of EDS (75 mg/kg body weight) to 
eliminate the existing adult Leydig cells from the testes. Rats were killed by CO2 four days after 
EDS, at which time the adult Leydig cell population was eliminated. Testes were decapsulated 
and the seminiferous tubules and interstitial tissues were mechanically separated with fine 
forceps under a dissection microscope. Tubules were placed in DMEM/F12 and M-199 medium 
supplemented with 0.1% BSA, 15mm HEPES, sodium bicarbonate (2.2 g/ml), 




5.5 g/ml; 5ng/ml). Tubules were cultured in 10ng/ml LH for up to 28 days. Culture media was 
collected and frozen for subsequent RIA testosterone assays. 
 
3Beta-Hydroxysteroid Dehydrogenase Activity 
 3βHSD enzyme activity was examined in both seminiferous tubules and isolated SLCs. 
To examine activity in tubules the tubules were washed with PBS and dried at room temperature 
for 20 minutes. Staining solution (0.4mM 5β-androstan-3β-ol-17-one steroid substrate, 1mg/ml 
nicotinamide adenine dinucleotide, and 0.2mg/ml tetranitro blue tetrazolium) was added to slides 
for 40 min and then removed by two successive washes in PBS. The slides were then placed in 
10% formalin for 30 min and examined. Tubules were examined after 1 and 28 days in culture 
with LH for 3βHSD activity. To examine 3βHSD enzyme activity in isolated cells, SLCs were 
first washed in PBS and then dried at room temperature for 20 min. Staining solution (0.4mM 
5β-androstan-3β-ol-17-one steroid substrate, 1mg/ml nicotinamide adenine dinucleotide, and 
0.2mg/ml tetranitro blue tetrazolium) was added to slides for 40 min and then removed by two 
successive washes in PBS. The slides were then placed in 10% formalin for 30 min and 
examined immediately. SLCs were examined after 1 and 28 days in culture with 2 M SAG and 
10ng/ml LH for 3βHSD activity. 
 
Effects of MEHP on tubule-associated stem Leydig cell differentiation 
As described above, seminiferous tubules were isolated from testes of EDS-treated rats 
four days after their EDS injection. Once separated and placed in culture medium, tubules were 




MEHP for 24 days. Treatments occurred 3-4 days apart and media was collected and frozen for 
RIA testosterone assay.  
 
Isolation of peritubular and perivascular stem Leydig cells 
 Rats were given a single intraperitoneal injection of EDS (75 mg/kg body weight) to 
eliminate the existing adult Leydig cells from the testes. Rats were killed by CO2 four days after 
EDS, at which time the adult Leydig cell population was eliminated. Testes were decapsulated 
and the seminiferous tubules and interstitial tissues were mechanically separated with fine 
forceps under a dissection microscope. Peritubular and perivascular cells were isolated by 
digesting the tubules and the interstitial issues, respectively, with 1mg/ml collagenase-D in 
DMEM/F12 media at 34⁰C with slow shaking. Interstitial tissues were digested first for 10 
minutes, then the supernatant was collected and fresh collagenase was added and the interstitial 
tissues were digested for an additional 20 minutes. Seminiferous tubules were digested twice for 
10 minutes each, collecting supernatant and adding fresh collagenase between the two. After the 
digestions, supernatants were filtered through a funnel to isolate SLCs. Following their isolation, 
cells were washed with PBS and then resuspended in DMEM/F12 media containing 5%FBS, 
10ng/ml FGF2 and 10ng/ml PDGFBB for one week. Once 80% confluent, the cells were split 
into treatment groups and the media was switched to DMEM/M199/ITS-Cell free media. Cells 
were cultured with 10ng/ml LH alone for the first week in culture, followed by 10ng/ml LH+ 
2 MSAG (an agonist of DHH) for weeks 2 and 3. Media was collected beginning after the first 
treatment of week 2 and each treatment subsequently thereafter and was used to measure 





Labeling cell proliferation with Click-iT EdU  
 Cell divisions were monitored with the Click-iT EdU imaging kit from Invitrogen. SLCs 
were labeled with EdU (10 M) for 24 h and examined immediately. Labeled nuclei (red) were 
examined by fluorescence microscopy. Slides were coverslipped with mounting media 
containing DAPI, which stains cell nuclei blue. Thus, the percentage of dividing cells was 
determined by calculating the number of cells labeled with both DAPI and EdU out of all the 
cells labeled with DAPI.  
 
Effect of phthalate exposure on SLC proliferation 
 The effects of phthalate exposure on SLC proliferation were assessed in two ways. To 
determine the effects of phthalates on testosterone production while cells were proliferating, 
SLCs were cultured with either 10ng/ml LH alone, 10ng/ml LH+0.01 M MEHP, 10ng/ml 
LH+0.1 M MEHP, or 10ng/ml LH+1.0 M MEHP for the first week in culture, followed by 
treatment with LH+2 M SAG for weeks two and three in culture. Media was collected after the 
first DHH treatment and was used measured via RIA. Treatments occurred twice a week, 3-4 
days apart. The effects of phthalate exposure on cell division were assessed with Click-iT EdU. 
Cells were plated into an 8-chamber slide coated with polylysine and treated with either 10ng/ml 
LH alone, or 10ng/ml LH+.01 M MEHP and four days later EdU label was added for 24 hours 
and then examined immediately.  
 




To determine the effects of phthalate exposure on differentiation, SLCs were isolated as 
described above, and following their expansion in medial with PDGFBB and FGF2, cells were 
split into four test groups. SLCs were cultured with 10ng/ml LH alone for the first week, 
followed by 10ng/ml LH+2 M SAG, 10ng/ml LH+2 M SAG+0.01 M MEHP, 10ng/ml 
LH+2 M SAG+0.1 M MEHP, or 10ng/ml LH+2 M SAG+1.0 M MEHP for week 2, and then 
10ng/ml LH+2 M SAG for week 3 in culture. Media was collected after the first SAG treatment 
and for each subsequent treatment and was used to measure testosterone via RIA. Treatments 
occurred twice a week, 3-4 days apart.  
 
qPCR  
qPCR was performed to determine P450scc mRNA expression levels. RNA was 
extracted from SLCs from tubules that were treated with either LH alone, or LH+0.1uM MEHP 
during week one, as well as from SLCs from interstitial tissues treated with either LH alone or 
LH+0.01uM MEHP during week two. RNA was extracted by giving cells 300 L of Triazol 
reagent following the protocol provided by Ambion by Life Technologies. Purity of RNA in the 
isolated smaple was measured using the Nanodrop 2000. Following the isolation of RNA, cDNA 
was synthesized using the protocol and master mix provided by Applied Biosystems. Mastermix 
was added to the RNA samples and then the samples were run through a reverse transcription 
thermal cycler to synthesize cDNA. Finally, once cDNA was synthesized, the standard 96-well 
PCR plate was prepared in accordance with the Thermofisher protocol. Actin primers were used 
as a control, while P450scc primers were used to determine the expression levels of the mRNA 






Seminiferous tubule-associated stem Leydig cell proliferation and differentiation 
To assess the ability of the SLCs to repopulate the surface of the seminiferous tubules 
and differentiate into testosterone-producing Leydig cells, seminiferous tubules devoid of Leydig 
cells as a consequence of EDS pre-treatment were isolated from Brown-Norway rat adult testes 
and cultured in vitro (Fig. 2A). On the first day in culture, the tubules were 3βHSD negative 
(Fig. 2B) indicating a lack of steroidogenic Leydig cells. After 28 days of culture with LH 
however, 3βHSD+ cells appeared on the surface of the tubules (Fig. 2C). The appearance of the 
cells demonstrates that the seminiferous tubules provide the infrastructure necessary to allow the 
SLCs on their surfaces to transition from SLCs on their surfaces to differentiate into 
steroidogenic cells, presumacly ALCs.  
Figure 3 shows that the proliferation and then differentiation of the stem Leydig cells on 
the surface of tubules cultured with LH occurred in distinct times of culture. Stem Leydig cell 
(SLC) proliferation occurred during the first week in culture with LH (Fig. 3 above), with little if 
any differentiation. Then, beginning at week 2 in culture, cells began to differentiate, and over 
the course of the following 2-3 weeks, produced increasing amounts of testosterone (Fig. 3 
below). Thus there was SLC proliferation and then decline in proliferation that preceded 
increased cell differentiation, the latter resulting in testosterone production. 
 




 Figure 4 shows the effects of increasing doses of phthalate exposure on the differentiation 
of stem Leydig cells residing on the surface of the tubules. For these studies, isolated 
seminiferous tubules lacking ALCs were separated into three groups and cultured in vitro. The 
control group was given only LH. The test groups were given either LH+0.2 M MEHP or 
LH+1.0 M MEHP. RIA was performed to measure testosterone levels in the media. As 
previously described, differentiation and thus testosterone production began around week 2 in 
culture. Thus, for the first week in culture for all three groups, testosterone production was 
negligible. Beginning at week 2, there was a gradual increase in testosterone observed in the 
control group, with the highest amount of testosterone produced by day 24. While the trend in 
testosterone production was the same for the two MEHP-treated groups, the amounts of 
testosterone produced by the tubules exposed to MEHP were less. The tubules exposed to 0.2 M 
MEHP produced less testosterone than control, with the biggest gap seen at day 24. The tubules 
exposed to 1.0 M MEHP produced the least testosterone at each day that testosterone was 
measured (Fig. 4). Thus, there was a dose-dependent inhibition of testosterone produced by 
Leydig cells on the surface of tubules exposed to phthalates. However, whether this was a result 
of a direct effect of phthalate on the differentiating stem cells or an indirect effect on these cells 
via effects on the tubule niche could not be determined because the cells were associated with the 
tubules.  
 
Isolation, proliferation and differentiation of SLCs from the surfaces of seminiferous 
 We wished to determine whether there were direct effects of stimulatory factors on the 




seminiferous tubules from EDS-treated rats were digested with collagenase. This yielded a 
heterogeneous cell population that included SLCs.  The cells obtained were cultured for one 
week in media containing growth factors known from previous studies of culture seminiferous 
tubules to facilitate proliferation of SLCs, namely PDGFBB and FGF2. This resulted in cells in 
the culture dishes reaching 80% confluence over the course of the seven days in culture (not 
shown).  Dividing cells were labeled with EdU. Active cell division was seen during the first 
week of culture (Fig. 5A). After this point in time, cells were split and they were cultured in 
serum-free media.  
To determine whether, after their proliferation, cells could be induced to differentiate, the 
cells were cultured with LH plus an agonist of DHH, SAG, shown to induce differentiation by 
cells associated with seminiferous tubules. After 7-10 days in culture, there was a gradual 
increase in testosterone production over time (Fig. 5B). Cells were negative for 3βHSD after 1 
day in culture (Fig. 5C), whereas those cultured for 28 days with LH + SAG stained positively 
for 3βHSD (Fig. 5D). The staining results were consistent with testosterone production and 
further demonstrated that the cells had transitioned from SLCs into ALCs 
 
Effects of MEHP on SLC proliferation 
With the knowledge that proliferation and differentiation are temporally separated both in 
vivo and in the seminiferous tubule culture system, the possibility that MEHP may affect SLC 
proliferation and differentiation differently was tested. Cells were obtained from collagenase-
treated tubules, and cultured in media containing the growth factors, FGF2 and PDGFBB, which 




Then, the SLCs were split into two treatment groups—LH only or LH+0.1 M MEHP. Cells 
were treated twice during one week, three days apart, and after the second treatment cells were 
EdU labeled for 24 hours and observed the following day. Labeled cells cultured with LH alone 
are shown in Figure 6A. Greater numbers of labeled cells were seen when the cells were cultured 
with LH plus 0.1µM MEHP (Fig. 6B). These observations are quantified in the graph shown in 
Figure 6C; the percentage of EdU-labeled cells was greater in response to exposure to 
LH+MEHP than LH alone.  
Next, the effects of MEHP exposure during the proliferation period on subsequent 
testosterone production were assessed (Fig. 7 above). For these studies, cells obtained by 
collagenase digestion of the seminiferous tubules were first cultured in media containing FGF2 
and PDGFBB to allow for their expansion in vitro. Then, cells were split into four different test 
groups. For the first week in culture, cells received two treatments of either LH alone, 3-4 days 
apart, or of LH plus one of three concentrations of MEHP: 01µM, 0.1µM, or 1.0µM. Then, for 
weeks two and three, cells received only LH+DHH, again twice a week 3-4 days apart. 
Testosterone produced by cells cultured with LH plus the lowest dose of MEHP, 0.01µM 
increased compared to testosterone production in response to LH or LH plus the two higher 
MEHP doses (0.1µM and then 1.0µM) The observed increased in proliferative activity suggests 
that the increase in testosterone observed may be due to an increase in cell number, i.e. more 
cells producing testosterone causing an overall increase in testosterone. Preliminary qPCR results 
(Fig. 7 below) indicated that levels of P450scc were consistent with the testosterone results: 
LH+0.1µM MEHP during week one in culture followed by LH+SAG for weeks two and three 





Effects of MEHP on SLC differentiation  
 To determine the effects of MEHP exposure on SLC differentiation, SLCs from 
seminiferous tubules were isolated and cultured in media containing FGF2 and PDGFBB to 
allow for their expansion. Following one week in expansion media, SLCs were split into four test 
groups and were treated twice a week for one week, 3-4 days apart. For the first week in culture, 
all four groups received LH alone. For week two, cells received either LH+SAG alone, 
LH+SAG+0.01µM MEHP, LH+SAG+0.1µM MEHP, or LH+SAG+1.0µM MEHP. For week 
three, all received only LH+SAG. There was an observed decrease in testosterone produced by 
SLCs at each MEHP concentration compared to LH-treated controls (Fig. 8). 
Additionally, in preliminary studies, interstitial tissue was isolated and cultured for a 
week in media containing FGF2 and PDGFBB to allow for the expansion of putative stem cells, 
and afterward in media containing LH+SAG, LH+SAG+0.01µM MEHP, LH+SAG+0.1µM 
MEHP, or LH+SAG+1.0µM MEHP. LH+SAG stimulated testosterone production. As with cells 
derived from the tubules, there was a decrease in testosterone produced by the interstitial tissue 
cells at each MEHP concentration compared to LH-treated controls (Fig. 9 above). Initial qPCR 
experiments to examine the expression levels of P450scc corroborated the data found from 
measuring testosterone. In these studies, message levels of the P450scc were determined in cells 
isolated from interstitial tissue treated with LH only for the first week in culture, followed by 
either LH+SAG or LH+SAG+0.01µM MEHP for week two, and then LH+SAG for week three. 
Preliminary data shows that there is a decrease in expression levels of P450scc in those cells 




to determine what, if any, additional steps of testosterone production may be targeted and altered 
as a result of MEHP exposure. 
 
DISCUSSION 
The Barker hypothesis of the fetal origins of adult disease has laid the foundation for 
discerning how adverse in utero influences can cause metabolic and physiological consequences 
that pose health risks in the adult [De Boo et al, 2006]. This has since been expanded to study 
how various exposures and stressors—whether environmental, nutritional, or emotional—can 
alter the developmental programming that occurs in the fetus to cause disease states that persist 
throughout the life of an adult, and spans areas of life that move beyond metabolic health and 
function to include areas such as cognitive and emotional health [Roth et al, 2009]. Often, the 
persistent effects occur through alterations in epigenetic marks, commonly DNA methylation, 
that result in altered gene expression and irregular development [Roth et al, 2009]. However, not 
all exposures result in changes in epigenetics, and yet, there are still negative health and 
developmental outcomes that are seen well into adulthood following an early life exposure. In 
these instances, it may be plausible to wonder whether a particular stem cell population was 
targeted and affected by the exposures.   
Leydig cells mature during puberty in rats and form from a stem Leydig cell population 
that is present in the neonatal testis [Ge et al, 2006; Zhang et. al, 2008]. Once they are 
established in the adult rat testis—at a population of about 25 million cells in the testis interstitial 
space—they provide the male with testosterone necessary for reproductive health and function 




are experimentally removed, they rarely turn over [Benton et al 1995; Teerds et al 1999]. 
However, if elimination of the Leydig cells does occur, stem cells in the testis are able to first 
proliferate to repopulate the interstitial space, and then differentiate from SLCs to ALCs and thus 
restore testosterone production in the male [Davidoff et al, 2004; Kerr et al, 1985; Stanley et al, 
2012; Teerds et al, 1999].  
Each stem cell population has a specific niche—an anatomic location with specific 
function that provides the architecture for the stem cells to reside [Scadden, 2006]. The niche 
also provides the stem cells with the appropriate signals required for their proliferation and self-
renewal, or their differentiation into a specific cell lineage [Li et al, 2016; Scadden, 2006]. For 
the Leydig stem cell, there is recent evidence that the niche at least in part is represented by the 
seminiferous tubules [Li et al, 2016; Stanley et al, 2011]. The tubules provide the physical 
surface on which the stem cells reside, fulfilling its anatomic role [Li et al, 2016; Stanley et al, 
2011]. Additionally, Sertoli cells from within the tubules secrete specific paracrine factors that 
serve to dictate SLC proliferation and differentiation in a precisely regulated manner [Li et al, 
2016].  
Among the chemicals that pose a severe threat to the developing fetus are endocrine 
disrupting compounds [Akingbemi et al, 2011]. Endocrine disruptors can occur naturally in the 
environment, or as a consequence of man-made chemicals and compounds [Gregoraszczuk and 
Kovacevic, 2014; Kopras, 2014]. Their general mechanism of action is characterized by delayed 
or otherwise altered hormone function or development [Akingbemi et al, 2011]. Due to the 
extreme sensitivity of many hormones in the body and the precise windows of development that 




or in too large a quantity it can cause altered expression of a specific cellular pathway. Similarly, 
if hormone synthesis is inhibited or delayed as a result of an exposure to endocrine disruptors, 
development may be delayed or impaired [Borch et al, 2006; David et al, 2006; Huand et al, 
2012].  
Phthalates—synthetic diesters of phthalic acid—are a family of plasticizing chemicals 
used in a variety of medical devices and consumer products to provide rigidity and to also act as 
solvents to provide lubrication and flexibility [Buckley et al, 2012; Kablock et al, 2006; Schettler 
et al, 2006]. The two most commonly used phthalates are di-2-ethylhexyl phthalate (DEHP) and 
di-n-butyl phthalate (DBP). Phthalates have been classified as endocrine disruptors due to their 
ability to impair human reproductive and developmental health. Specifically, they are able to act 
as anti-androgenic compounds resulting in abnormal testosterone production and altered male 
reproductive tract development [Akingbemi et al, 2001; Zhang et al, 2008]. Additionally, the 
metabolites of DEHP and DBP, MEHP and MBP, respectively, have been shown to disrupt 
Leydig cell structure and function in males [Borchea et al, 2006; David et al, 2006; Huant et al, 
2012].  
Various in vivo animal experiments have looked at the effect of in utero exposure to 
phthalates on steroidogenic enzyme function in developing and adult Leydig cells, testosterone 
production and reproductive tract development in male offspring [Latini et al, 2004]. These 
studies have suggested that these early life phthalate exposures can have adverse effects that 
persist throughout the adult male life [Ge et al, 2009; Zhang et al, 2008]. Additional 
epidemiologic studies have found correlational evidence suggesting a link between in utero/early 




cryptorchidism in male offspring [Krysiak-Baltyn et al, 2012; Main et al, 2006]. However, an 
exact mechanism for how phthalates produce their effects is unknown. Some studies have 
suggested that there is impairment of the steroidogenic enzymes necessary for testosterone 
production [Borchea et al, 2006; Ge et al, 2007; Kilcoyne et al, 2014; Lin et al, 2009; Shultz et 
al, 2001]. Others have suggested that is it independent of the function of these enzymes, but 
rather (or additionally) that there are adverse effects on the adult adrenal glands, resulting in 
impaired communication between the adrenal gland and the testis [Ge et al, 2005; Martinez-
Arguelles et al, 2009; Martinez-Arguelles et al, 2011]. Additionally, since the adult Leydig cells 
are not present in the testes at the time of these early life exposures but rather stem cells that give 
rise to the Leydig cells, it is presumably the stem Leydig cell population that is being targeted 
and affected.  
In order to address the questions of whether or not there are effects of phthalate exposure 
that directly impair SLC proliferation and differentiation, and thus adult Leydig cell function, we 
used both isolated seminiferous tubules and cells from the tubules, the latter including SLCs. 
First, we used isolated seminiferous tubules from EDS-treated rats to demonstrate that SLCs are 
present on their surfaces, and that over time in culture with LH the stem cells are able to 
proliferate and then differentiate into 3 HSD+ Leydig cells capable of producing testosterone. 
Sertoli cells within the seminiferous tubules communicate with the stem cells on the surface of 
the tubules through secretion of paracrine factors that act as cues to stimulate stem cell 
proliferation and then differentiation. The two phases occur separately in vivo and this temporal 
separation is maintained when the seminiferous tubules are cultured in vitro [Odeh et al, 2014; 




The seminiferous tubule culture system was then used to assess the effects of exposure to 
MEHP on SLC differentiation. The advantage of this system is that it can be used to examine the 
development of Leydig cells from stem cells apart from other organ systems in the context of 
their niche. The results indicated a decline in testosterone produced by SLCs associated with 
tubules ther were exposed to MEHP compared to controls. This suggested that phthalates may 
exert their actions on the stem Leydig cells. However, since the cells were still residing in their 
niche, the potential for the niche to be implicated in the exposure and thus have a role in causing 
adverse effects on Leydig cells could not be ruled out. This led to our use of a stem Leydig cell 
culture system, where SLCs are separated from their niche and cultured in vitro with factors that 
are added to the culture media, not emanating from the tubules.  
Using the stem Leydig cell culture system, we were able to demonstrate that SLCs can be 
isolated from the surfaces of seminiferous tubules and interstitial tissues and cultured 
successfully in vitro.  The administration of niche-specific factors was found to facilitate their 
proliferation and differentiation in a temporally distinct manner. For instance, when the whole 
tubules are cultured, it was found that PDGFBB and FGF2 are released from the niche during the 
first week in culture, leading to the proliferation of the stem cells on the tubule surfaces. DHH is 
secreted by Sertoli cells beginning the second week in culture, which stimulated SLC 
differentiation. In experiments, an agonist of DHH, SAG, was used. These factors can be 
administered in the same time frame when the isolated SLCs are cultured. We found that this 
approach could be used to maintain the temporal separation between proliferation and 




produce testosterone. Ultimately, the stem cells could be stimulated to differentiate into 3 HSD+ 
cells that are capable of producing testosterone.  
Preliminary studies assessed the putative SLC population located in the interstitial tissue 
of the testis. Using the same collagenase digestion system used to isolated SLCs from 
seminiferous tubules, putative SLCs were isolated from interstitial tissue and cultured with LH 
alone for one week followed by LH+SAG, and were found to produce testosterone. While 
evidence from Stanley et al, 2011 rejected the existence of stem Leydig cells amongst the 
interstitial tissues, this may be because they were removed from the their local source of DHH 
secreted from Sertoli cells within the seminiferous tubules when the two tissues were cultured 
separately. Thus, the putative SLCs never differentiated to gain the capacity to produce 
testosterone. It would be worthwhile to culture the interstitium from testes pre-treated with EDS 
with LH+SAG to see if there are putative SLCs amongst the interstitial tissue that are capable of 
differentiating and producing testosterone. If testosterone is successfully produced then it may be 
interesting to assess the effects of factors known to facilitate proliferation such as FGF2 and 
PDGBFF on SLCs associated with the interstitial tissue to see if they play the same role in a 
more complex environment than a culture dish, that is still distinct from the niche.   
The use of the isolated cells provided the ability to assess whether phthalate exposures act 
directly on SLCs to affect their proliferation and/or differentiation to form testosterone-
producing Leydig cells. An increase in testosterone production was seen compared to controls 
when SLCs were exposed to MEHP while the cells were proliferating. Additionally, there was an 
increase in cell division in proliferating SLCs exposed to MEHP shown with EdU labeling, as 




increase in testosterone observed in these cells after phthalate exposure. The increase in 
testosterone produced may be a result of an increase in the number of cells capable of producing 
testosterone. Alternatively or additionally, there may be an increased capacity of each cell to 
produce testosterone. When SLCs were exposed to MEHP while they were differentiating, 
however, there was a decrease in testosterone produced by Leydig cells compared to controls. 
These results are consistent with the inhibition of testosterone produced by SLCs residing of the 
surface of the tubules following exposure to MEHP.  
While there is an observed decrease in testosterone produced by differentiating Leydig 
cells, the exact mechanism through which this occurs is still to be determined. Thus, it is not 
known which enzymes or proteins might be responsible.  However, the fact that there is altered 
testosterone production—namely stimulation during proliferation and inhibition during 
differentiation—when exposures occur directly to SLCs during their differentiation phase 
indicates that there is a direct effect on the developing Leydig cells, perhaps involving effects on 
the steroidogenic enzymes or the developing Leydig cell itself. This is supported by the 
preliminary results from qPCR experiments demonstrating a decrease in P450scc mRNA 
expression in cells exposed to MEHP while differentiating compared to controls.  
It would be worthwhile to conduct additional studies of the steroidogenic enzymes, and 
particularly to compare results obtained to the expression of these enzymes when exposure is  in 
the context of the niche (i.e. using seminiferous tubules rather than isolated cells).  The 
objectives would be to determine if: 1) there are upregulated or downregulated expression levels 
of particular genes and proteins; and 2) whether the niche (seminiferous tubules) influences the 




While the isolated cell culture system allowed for examining the effects of specific niche 
factors and environmental toxins on stem Leydig cell proliferation, differentiation and 
development, the population of cells that was used was heterogeneous. The cells isolated from 
the collagenase digestion were not solely SLCs, but included other cell types such as germ cells. 
During the time that these experiments were being performed, Chen et. al published a protocol 
for the isolation of SLCs using the CD90 cell surface marker to mark SLCs, and flow cytometry 
techniques to isolate and purify the SLCs. Thus, it is now possible to sort the heterogeneous cell 
population that is initially retrieved after collagenase digestion to end up with a homogenous 
CD90+ population of stem Leydig cells. It would be worthwhile to repeat the experiments 
performed above using the CD90 sorting technique to completely isolate the SLC population. 
This way, the possibility for any cell-cell communications or interactions even outside of the 
niche are eliminated and the effects of niche-specific factors and environmental toxins on the 
stem Leydig cells directly can be examined.  
In addition to eventually placing these studies back in the context of the testis and whole 
body environments, it should be noted that the data reported is from exposures of cells to only 
MEHP. However, in reality, these sorts of isolated exposures are rare. Instead, humans and 
animals are exposed to combinations of phthalates such as DEHP and DBP, or phthalates and 
other toxicants/chemicals that may have synergistic or additive effects. Thus, although these 
experiments provide data relating to the effects of and mechanisms of phthalate mediated 
toxicity, further studies examining the effects of multiple phthalates together should be 
performed in extensive detail to determine if there are indeed additive or multiplicative effects of 




tubules culture systems provide a platform to perform experiments in parallel to determine 
effects on the Leydig cells themselves.  
Overall, the above studies demonstrate the development of a novel stem Leydig cell 
culture system in which SLCs are isolated from the surfaces of seminiferous tubules and 
interstitial tissue first proliferate and then differentiate in vitro. The use of these cells allows for 
the identification of the effects of suspected niche-specific factors on the proliferation and 
differentiation of the SLCs in culture and a way to assess the effects of exposure to 





















Figure 1. Steroidogenic pathway in Leydig cells. Stimulation by LH leads to increased cAMP which 
stimulates the transport of cholesterol into the mitochondria, where it is converted to pregnenelone by 
P450scc. Pregnenelone is then transported to the smooth ER where 3-βHSD converts it to progesterone. 
After a series of metabolic steps, progesterone is eventually converted into testosterone. (Taken from 













Figure 2. Leydig cell development on the surface of cultured seminiferous tubules. A:  Isolated 
seminiferous tubules. B: There are no 3βHSD+ cells on the surface of the tubules on Day in culture. C: 










Figure 3. In vitro tubule-associated SLC proliferation and differentiation. Stem Leydig cell (SLC) 
proliferation (above) occurred on the surface of seminiferous tubules during the first week in culture with 
LH. SLCs on the surface of the tubules began to differentiate and produced increasing amounts of 
testosterone beginning at week 2 in culture (below). The decline in SLC proliferation coincided with the 






Figure 4. Seminiferous tubules cultured in vitro. Tubules were cultured with LH alone, LH+0.2 g /ml 
MEHP, or LH + 1 g/ml MEHP for up to 24 days. There was an observed dose-dependent decrease in 






































Figure 5 Proliferation of Isolated SLCs. A. EdU labeling of SLCs isolated from seminiferous tubules. 
All cell nuclei are stained blue with DAPI. Those that are pink are co-labeled with EdU and are actively 
dividing. These are presumably the SLCs. B. Time course for the differentiation of SLCs isolated from 
seminiferous tubules. SLCs were obtained from seminiferous tubules by collagenase digestion and 
cultured in vitro. Cells were cultured with LH + 2 M SAG. Differentiation was assessed by measuring 
testosterone in the media over time. As with isolated tubules, the cells began to produce testosterone after 
about a week in culture after administration of SAG. C: There are no 3βHSD+ cells amongst the SLCs 





Figure 6. Proliferation of SLCs isolated from seminiferous tubules with and without MEHP 
exposure. Cell nuclei are stained blue with DAPI. Cells that are pink are positively labeled with EdU. A: 
SLCs cultured with LH alone. B:  SLCs cultured with LH+0.1 M MEHP. Greater numbers of EDU-
labeled cells are apparent. C: Percentage of EdU-labeled SLCs in response to LH alone or LH+MEHP in 
SLCs isolated from seminiferous tubules. These results indicate that exposure of the SLCs to MEHP 
during week 1 of culture results in increased numbers of dividing cells compared to SLCs cultured with 







Figure 7. Above: Testosterone production by SLCs from seminiferous tubules cultured with LH alone, 
LH+ 0.01 M MEHP, LH+0.1 M MEHP, or LH+ 1.0 M MEHP during week 1, and then with LH+ 
Desert Hedgehog (DHH) during week 2 to stimulate differentiation. Increased testosterone production 
resulted from culture with MEHP during week 1, with 0.01 M MEHP. These results are consistent with 
the increased numbers of cells resulting from MEHP treatment during week 1. Below: Relative 
expression level of P450scc mRNA in cells treated with LH alone or LH+0.1 M MEHP during the first 
week in culture. P450scc expression levels are higher in those cells exposed to MEHP compared to 
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Figure 8. Testosterone produced by SLCs from seminiferous tubules in response to MEHP 
treatment during week 2 of culture. Testosterone production by SLCs cultured with LH alone during 
week 1, followed by LH+ DHH, LH+DHH+0.01 M MEHP, LH+DHH+0.1 M MEHP, or 
LH+DHH+1.0 M MEHP during week 2. Reduced testosterone production is seen with MEHP exposure, 
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Figure 9. Evidence of putative SLCs residing in the interstitial tissues and the effects of MEHP on 
this population. Above: Putative SLCs isolated from interstitial tissue were treated with LH alone during 
week 1, followed by LH+ DHH, LH+DHH+0.01 M MEHP, LH+DHH+0.1 M MEHP, or 
LH+DHH+1.0 M MEHP during week 2. Similar to SLCs from seminiferous tubules, there is a decreased 
in testosterone production as a result of MEHP exposure. Below: Preliminary qPCR results show the 
relative expression levels of P450scc mRNA in cells treated with LH alone week 1 then LH+DHH or 
LH+DHH+0.01 M MEHP during week 2 in culture. P450scc expression levels are lower in those cells 
exposed to MEHP compared to controls. This is consistent with results from the testosterone assay 
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